Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
Jianmin ChenLucy Victoria NorlingDianne CooperPublished in: Cells (2021)
Rheumatoid arthritis is a chronic, systemic inflammatory disease that carries an increased risk of mortality due to cardiovascular disease. The link between inflammation and atherosclerotic disease is clear; however, recent evidence suggests that inflammation may also play a role in the development of nonischemic heart disease in rheumatoid arthritis (RA) patients. We consider here the link between inflammation and cardiovascular disease in the RA community with a focus on heart failure with preserved ejection fraction. The effect of current anti-inflammatory therapeutics, used to treat RA patients, on cardiovascular disease are discussed as well as whether targeting resolution of inflammation might offer an alternative strategy for tempering inflammation and subsequent inflammation-driven comorbidities in RA.
Keyphrases
- rheumatoid arthritis
- oxidative stress
- cardiovascular disease
- disease activity
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- interstitial lung disease
- healthcare
- mental health
- prognostic factors
- metabolic syndrome
- systemic lupus erythematosus
- pulmonary hypertension
- drug delivery
- cancer therapy
- cardiovascular risk factors
- single molecule
- left ventricular
- systemic sclerosis
- cardiac resynchronization therapy